Finnrick - Ensuring a Safer and More Transparent Supply Chain
Lisa Biopeptide

Lisa Biopeptide

Tirzepatide

Finnrick tested 7 samples of Tirzepatide (GLP-1 and GIP agonist) from Lisa Biopeptide between 30 Oct 2025 and 3 Mar 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).

Finnrick Rating™
Lisa Biopeptide
Tirzepatide
Tested 7 Samples
Last test 3 Mar 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Lisa Biopeptide

Samples are tested in commercial labs

Tests Count

7

Scores

AVG4.8MIN0.0MAX8.0

Last

3 Mar 2026

First

30 Oct 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
3 Mar 2026View1.35mg2mg-60.0%74.50%(no batch ID)White Label / Silver Crimp / Blue CapLab EPublic
1 Mar 2026View8.030mg30.9mg+3.0%99.90%(no batch ID)Silver Label / Silver Crimp / Black CapLab GPublic
20 Feb 2026View6.330mg26.8mg-10.7%99.90%(no batch ID)No Label / Copper Crimp / Clear CapLab EPublic
20 Feb 2026View4.75mg3.65mg-27.0%99.83%(no batch ID)No Label / Silver Crimp / White CapLab EPublic
2 Feb 2026View0.05mg
⚠️ Sample does not contain Tirzepatide
(no batch ID)No Label / Silver Crimp / Blue CapLab EPublic
19 Jan 2026View7.315mg14.1mg-6.0%99.77%(no batch ID)No Label / Silver Crimp / Clear Pink CapLab EPublic
30 Oct 2025View6.110mg9.24mg-7.6%99.50%(no batch ID)White Label / Silver Crimp / Yellow CapLab GPublic